Evidence check: HDL in the context of Wechseljahre

Menopause (Wechseljahre) involves hormonal shifts that can alter lipid profiles. HDL cholesterol ('good' cholesterol) shows a nuanced pattern: during perimenopause HDL may initially rise, but later it can decline or shift toward less protective subtypes (smaller HDL particles). Evidence is based on observational studies and is rated 'human-moderate' – no large RCTs prove a causal menopause effect on HDL. Caveat: isolated low HDL is not a standalone risk factor; it must be interpreted alongside LDL, triglycerides, and overall cardiovascular risk. Lifestyle interventions (exercise, Mediterranean diet, smoking cessation) remain the most evidence-supported ways to support HDL. Hormone therapy may raise HDL but its clinical benefit is debated. The provided context lacks direct data on HDL and menopause; this answer relies on general medical knowledge. Consumers should not over-focus on a single biomarker – a comprehensive health check including blood pressure, glucose, and inflammation markers is more informative.